Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th ASH Annual Meeting
MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio today presented updated positive clinical data on Orca-T during an oral presentation at the American Society of Hematology Annual Meeting.
